Should we be combining local tumor therapies with immunotherapies as standard?

被引：3
|
作者：
Baues, Christian [1 ,2 ,3 ]
Schlaak, Max [1 ,4 ]
von Bergwelt-Baildon, Michael [1 ,5 ,6 ]
Theurich, Sebastian [1 ,5 ,7 ]
机构：
[1] Univ Hosp Cologne, Radio Immune Oncol RIO Consortium, Cologne, Germany
[2] Univ Hosp Cologne, Dept Radio Oncol, Cologne, Germany
[3] Univ Hosp Cologne, CyberKnife Ctr, Cologne, Germany
[4] Univ Hosp Cologne, Skin Canc Ctr, Dept Dermatol & Venereol, Cologne, Germany
[5] Univ Hosp Cologne, Ctr Integrated Oncol CIO Koln Bonn, Dept Internal Med, Cologne, Germany
[6] Univ Hosp Cologne, Dept Internal Med, CII, Cologne, Germany
[7] Univ Hosp Cologne, Dept Internal Med, Canc & Immunometab Res Grp, Cologne, Germany
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 18期
关键词：
abscopal effect; CTLA4; electrochemotherapy; immune checkpoint inhibition; immunogenic cell death; immunotherapy; ipilimumab; local treatment; nivolumab; PD-1; pembrolizumab; radiotherapy; talimogene laherparepvec; T-VEC; ADVANCED MELANOMA; UNTREATED MELANOMA; RADIATION-THERAPY; IPILIMUMAB; NIVOLUMAB; SURVIVAL; RADIOTHERAPY; COMBINATION;
D O I：
10.2217/fon-2017-0150
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1573 / 1575
页数：3
相关论文
共 50 条
  • [31] Should we integrate viscoelastic assays with standard coagulation screening?
    Visweshwar, Nathan
    Jaglal, Michael
    Patel, Ankita
    Laber, Damian
    Sokol, Lubomir
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (03) : 141 - 143
  • [32] Uninformed Origins: Should We Be Advising Parents on the Source of Medicines and Therapies?
    Tara E. Ness
    Zachary J. Tabb
    Janet Malek
    Frank X. Placencia
    Health Care Analysis, 2023, 31 : 186 - 195
  • [33] Uninformed Origins: Should We Be Advising Parents on the Source of Medicines and Therapies?
    Ness, Tara E.
    Tabb, Zachary J.
    Malek, Janet
    Placencia, Frank X.
    HEALTH CARE ANALYSIS, 2023, 31 (3-4) : 186 - 195
  • [34] Clinical Trial Designs for New Therapies: When Should We Randomize?
    Hunsberger, S.
    CANCER RESEARCH, 2012, 72
  • [35] Why should we need the gut microbiota to respond to cancer therapies?
    Viaud, Sophie
    Daillere, Romain
    Yamazaki, Takahiro
    Lepage, Patricia
    Boneca, Ivo
    Goldszmid, Romina
    Trinchieri, Giorgio
    Zitvogel, Laurence
    ONCOIMMUNOLOGY, 2014, 3 (01)
  • [36] Paediatric weight 'guesstimation' - can we, should we, and how do we compare to standard formulae?
    Gardner, S.
    ACTA PAEDIATRICA, 2008, 97 : 149 - 149
  • [37] If We Think Globally, Should We Write Local, National, or Imperial History?
    Sidbury, James
    NWIG-NEW WEST INDIAN GUIDE-NIEUWE WEST-INDISCHE GIDS, 2013, 87 (1-2): : 95 - 101
  • [38] Targeting neuroendocrine tumor: mixing standard options with novel therapies
    Eric Raymond
    Chantal Dreyer
    Sandrine Faivre
    Targeted Oncology, 2012, 7 : 151 - 152
  • [39] Targeting neuroendocrine tumor: mixing standard options with novel therapies
    Raymond, Eric
    Dreyer, Chantal
    Faivre, Sandrine
    TARGETED ONCOLOGY, 2012, 7 (03) : 151 - 152
  • [40] Forecasting economic growth by combining local linear and standard approaches
    Fritz, Marlon
    Forstinger, Sarah
    Feng, Yuanhua
    Gries, Thomas
    JOURNAL OF APPLIED STATISTICS, 2024,
12345